RecruitingPhase 3NCT06229210Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderSponsor: Intra-Cellular Therapies, Inc.Coppell, TX · Fort Worth, TX · Houston, TX · +56 more sites
RecruitingPhase not listedNCT07379827Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)Sponsor: Bristol-Myers SquibbAustin, TX · Dallas, TX · Fort Worth, TX · +52 more sites
Not yet recruitingPhase 4NCT06923891An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia PatientsSponsor: Vanguard Research GroupRichmond, TX